Biomerica, Inc. (BMRA)
2.09
+0.04
(+1.95%)
USD |
NASDAQ |
Oct 06, 16:00
2.09
0.00 (0.00%)
After-Hours: 20:00
Biomerica Cash from Operations (Quarterly) : -0.912M for May 31, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| May 31, 2026 | -0.912M |
| February 28, 2026 | -1.25M |
| November 30, 2025 | -0.991M |
| August 31, 2025 | -0.268M |
| May 31, 2025 | -0.661M |
| February 28, 2025 | -1.045M |
| November 30, 2024 | -0.791M |
| August 31, 2024 | -1.344M |
| May 31, 2024 | -1.044M |
| February 29, 2024 | -1.801M |
| November 30, 2023 | -0.842M |
| August 31, 2023 | -1.674M |
| May 31, 2023 | -0.9627M |
| February 28, 2023 | -1.725M |
| November 30, 2022 | -1.213M |
| August 31, 2022 | -1.573M |
| May 31, 2022 | -4.258M |
| February 28, 2022 | 2.358M |
| November 30, 2021 | 1.343M |
| August 31, 2021 | 0.0758M |
| May 31, 2021 | -1.008M |
| February 28, 2021 | -1.364M |
| November 30, 2020 | -1.283M |
| August 31, 2020 | -1.597M |
| May 31, 2020 | -3.495M |
| Date | Value |
|---|---|
| February 29, 2020 | -0.4369M |
| November 30, 2019 | -0.3578M |
| August 31, 2019 | -0.0082M |
| May 31, 2019 | -0.9863M |
| February 28, 2019 | -0.2566M |
| November 30, 2018 | -0.2444M |
| August 31, 2018 | -0.7567M |
| May 31, 2018 | -0.322M |
| February 28, 2018 | -0.4888M |
| November 30, 2017 | -0.2386M |
| August 31, 2017 | -0.1247M |
| May 31, 2017 | -0.3335M |
| February 28, 2017 | -0.0815M |
| November 30, 2016 | -0.236M |
| August 31, 2016 | -0.0719M |
| May 31, 2016 | -0.0137M |
| February 29, 2016 | 0.23M |
| November 30, 2015 | -0.2294M |
| August 31, 2015 | -0.1956M |
| May 31, 2015 | -0.0866M |
| February 28, 2015 | -0.5029M |
| November 30, 2014 | 0.0404M |
| August 31, 2014 | 0.1436M |
| May 31, 2014 | -0.0094M |
| February 28, 2014 | -0.1128M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Univec, Inc. | -0.0157M |
| Lantheus Holdings, Inc. | 92.20M |
| Zomedica Corp. | -2.515M |
| IDEXX Laboratories, Inc. | 347.16M |
| Neogen Corp. | 30.20M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 0.018M |
| Cash from Financing (Quarterly) | 0.871M |
| Free Cash Flow | -3.422M |
| Free Cash Flow Per Share (Quarterly) | -0.2912 |
| Free Cash Flow to Equity (Quarterly) | -3.084M |
| Free Cash Flow to Firm (Quarterly) | -0.894M |
| Free Cash Flow Yield | -56.32% |